Cancer Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-03-29 ms5000001900218307 来自北京

之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历：
25-Nov-2023 投稿
26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修）
14-Mar-2024 修回（由于工作还有其他原因17天才修回）
16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题）
17-Mar-2024 第2天修回，修回第2天就显示pending decision
28-Mar-2024 Accept
这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩

160 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-10-20 ms1000001788822123 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：结直肠癌
经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-07-12 ms1000001009157638 来自天津

偏重的研究方向：结直肠癌;临床
经验分享：3月21号投的，到现在还没一审结束，绝了

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-09-04 ms1000001788820000 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：今天年3月初 submitted
5.8under review
5.20 minor revision 2个reviewer各3条意见
5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。
reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-03-21 ms1000001834918815 来自浙江省

审稿速度:12.0 | 投稿命中率:50.0
经验分享：一审4个月，修回后2个多月还没还没结果。
这个期刊太慢了

111 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-07-07 ziecoe 来自重庆

审稿速度:2.0 | 投稿命中率:50.0
经验分享：27-Sep-2023 投稿， Undergoing initial checking
03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking
06-Oct-2023 Pending Editor Assignment
13-Oct-2023 Under Review
05-Dec-2023 Pending Recommendation
08-Dec-2023 Major Revision
26-Dec-2023 一审修回，退回，改格式，当天投回，
27-Dec-2023 Undergoing initial checking
28-Dec-2023 Pending Recommendation
17-Jan-2024 Under Review
08-Feb-2024 Pending Recommendation
27-Feb-2024 Under Review
13-Apr-2024 Major Revision
15-Apr-2024 二审修回，Undergoing initial checking
17-Apr-2024 Pending Recommendation
08-May-2024 Under Review
10-May-2024 Pending Recommendation
25-May-2024 Pending Decision
28-May-2024 Accept

95 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-04-19 ms1000001834918815 来自浙江省

二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。

111 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-07-12 ms1000000176525029 来自上海

想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了

106 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-04-02 ms7000001808447985 来自青海省

偏重的研究方向：肿瘤
经验分享：刚投的不知道结果，害怕

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2196078, encodeId=b48721960e8a3, content=之前投稿前还有等待过程中看了很多小伙伴的经验，对我的帮助很大，现在我也来分享一下我的投稿经历： 25-Nov-2023 投稿 26-Feb-2024 Major Revision（一共3个审稿人，第1个审稿人非常仔细，提了很多的问题，另外2个审稿人提的问题比较少，总体来说都很专业，而且没有故意为难，编辑部给了大修） 14-Mar-2024 修回（由于工作还有其他原因17天才修回） 16-Mar-2024 Minor Revision （大修回去2天就返回了小修意见，副编辑提了两点小问题） 17-Mar-2024 第2天修回，修回第2天就显示pending decision 28-Mar-2024 Accept 这次投稿过程非常顺利，中间提交返修稿的时候由于邮箱的问题导致提交不了，发邮件给编辑部很快就帮忙解决了，而且态度很好，感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73845585388, createdName=ms5000001900218307, createdTime=Fri Mar 29 14:56:05 CST 2024, time=2024-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2231920, encodeId=d411223192074, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌 经验分享：7月25号投的，到现在还没一审结束，前前后后催了好几次了，还是没信，真是急死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:35:41 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2214554, encodeId=7e902214554e6, content=偏重的研究方向：结直肠癌;临床 经验分享：3月21号投的，到现在还没一审结束，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Fri Jul 12 09:27:34 CST 2024, time=2024-07-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2224111, encodeId=1a6e2224111e6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：今天年3月初 submitted 5.8under review 5.20 minor revision 2个reviewer各3条意见 5.28 修回2天后accept杂志慢的阶段主要在处理和送审阶段。 reviewer给的意见都比较积极，因此revision以后应该没送外审，直接编辑部决定了，总体还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820000, createdTime=Wed Sep 04 23:30:05 CST 2024, time=2024-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：一审4个月，修回后2个多月还没还没结果。 这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2213669, encodeId=e63022136697d, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：27-Sep-2023 投稿， Undergoing initial checking 03-Oct-2023 退回，改格式，当天投回，变成Undergoing initial checking 06-Oct-2023 Pending Editor Assignment 13-Oct-2023 Under Review 05-Dec-2023 Pending Recommendation 08-Dec-2023 Major Revision 26-Dec-2023 一审修回，退回，改格式，当天投回， 27-Dec-2023 Undergoing initial checking 28-Dec-2023 Pending Recommendation 17-Jan-2024 Under Review 08-Feb-2024 Pending Recommendation 27-Feb-2024 Under Review 13-Apr-2024 Major Revision 15-Apr-2024 二审修回，Undergoing initial checking 17-Apr-2024 Pending Recommendation 08-May-2024 Under Review 10-May-2024 Pending Recommendation 25-May-2024 Pending Decision 28-May-2024 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8abb105234, createdName=ziecoe, createdTime=Sun Jul 07 00:08:26 CST 2024, time=2024-07-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2199315, encodeId=866f2199315f6, content=二审三个月才到pending recommendation。这个状态已经持续了10多天了，催稿也没用。怎么啊，毕业急需啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Fri Apr 19 14:46:34 CST 2024, time=2024-04-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214659, encodeId=55fc221465941, content=想问下能哪个地方可以看到审稿进度嘛已经under review 一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21a65422215, createdName=ms1000000176525029, createdTime=Fri Jul 12 18:33:38 CST 2024, time=2024-07-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196694, encodeId=d2ea219669442, content=偏重的研究方向：肿瘤 经验分享：刚投的不知道结果，害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f399221385, createdName=ms7000001808447985, createdTime=Tue Apr 02 21:29:16 CST 2024, time=2024-04-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2213353, encodeId=e7e1221335390, content=真的超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7f65326850, createdName=148be838m87暂无昵称, createdTime=Fri Jul 05 01:07:14 CST 2024, time=2024-07-05, status=1, ipAttribution=四川省)]

2024-07-05 148be838m87暂无昵称来自四川省

真的超级慢

112 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务